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Abstract 
The nested variant of urothelial carcinoma
(NVUC) is characterized by the presence of
benign-appearing  urothelial  carcinoma  cells
in  the  lamina  propria,  sparing  the  surface
urothelial involvement. NVUC shows aggres-
sive clinical course despite of benign-looking
histology.  Herein  reported  are  two  cases  of
NVUC. One is 80-year-old woman, and another
is 78-year-old man. In both cases, atypical cells
forming nests and tubules were seen in the
lamina  propria  without  surface  urothelial
involvement.  One  case  resembled  nephro-
genic  metaplasia  and  another  proliferated
Brunn’s nest or inverted papilloma. Immuno  -
histochemically,  both  cases  showed  positive
p53 and high Ki67 labeling, suggesting that
both  cases  are  malignant.  Immuno  histo  -
chemically, one case was characterized by pos-
itive  cytokeratins,  EMA,  p53,  Ki-67  (label-
ing=15%), α-methylacyl CoA racemase, CA19-
9,  and  MUC1,  and  another  case  by  positive
cytokeratins,  EMA,  p63,  p53,  Ki-67  (lebel-
ing=30%), CD10, CEA, and MUC1. Cyto  keratin
immunoprofiles  were  described  and  other
antigens’  expressions  were  shown.  The
patients  are  now  free  of  tumor  6  and  15
months  after  the  resection  of  the  bladder
tumor.
Introduction
The nested variant of urothelial carcinoma
(NVUC) of the urinary bladder is histological-
ly  characterized  by  bland,  benign-looking
urothelial carcinoma in lamina propria with
nested and tubular patterns and without over-
lying  urothelial  carcinoma  of  the  surface
urothelial layer.1,2 The atypia of NVUC is rela-
tively  mild.1,2 NVUC  resembles  hyperplastic
von-Brunn’s  nests,  nephrogenic  metaplasia,
and inverted papilloma. High grade neoplasms
with focal nests and tumors with overlying of
carcinoma in situ should not be included in
this variant.2 NVUC should be differentiated
from von-Brunn’s nest, nephrogenic metapla-
sia, prostatic carcinoma, and inverted papillo-
ma.1,2 Clinically,  NVUC  shows  relatively
aggressive course. 
NVUC of the urinary bladder is very rare,
and only less than 50 cases have been report-
ed.1 A PubMed search revealed only 8 reports
of NVUC.3-10 Herein reported are two cases of
NVUC with immunohistochemical findings.
Case Reports
Case #1
An 80-year-old woman consulted to our hos-
pital because of dysuria. A blood laboratory
test  showed  mild  hyperlipidemia.  Tumors
markers were within normal ranges. Bladder
endoscopy  revealed  a  nodular  tumor  and
transurethoral  resection  of  bladder  tumor
(TUR-BT) was performed. Histologically, atyp-
ical cells were present in the lamina propria
(Figure 1A and 1B). No tumor was seen in the
surface urothelium (Figure 1A). The atypical
cells formed small nests, and acinar forma-
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Figure 1. Case #1. A) Low power view of nest-
ed variant of urothelial carcinoma of the blad-
der. The atypical cells are present in the lami-
na propria. The surface epithelial cells are free
of tumor. HE, x50. B) High power view of A.
The atypical cells show mild atypia, and take
a form of vague nested and tubular patterns.
The features resemble nephrogenic metapla-
sia. HE, x 200. C) The atypical cells are posi-
tive for p53. Immuno  staining , x200. D) The
atypical cells show Ki-67 antigen. The Ki67-
labeling is 15%. Immu  nostaining, x200. E)
The atypical cells, particularly tubular cells,
show positive reaction of MUC1. Immuno  -
staining, x200.
A B
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tions were seen in a small number (Figure
1B). The cells had hyperchromatic nuclei and
enlarged nuclei (Figure 1B). The histological
features resembled nephrogenic metaplasia.
Mucin stains were negative. An immunohis-
tochemical study was performed with the use
of Dako’s envision method (Dako. Corp, Glu  -
strup, Denmark), as previously described.10,11
The immunohistochemical results are shown
in Table 1. Characteristic findings were posi-
tive cytokeratins, EMA, p53 (Figure 1C), Ki-67
(labeling=15%) (Figure 1D), α-methylacyl CoA
racemase (AMACR), CA19-9, and MUC1 (Figure
1E) (Table 1). Since p53 was positive and Ki-67
was relatively high, benign conditions such as
nephrogenic  metaplasia  and  proliferated  von
Brunn’s nest were denied. The final pathologi-
cal  diagnosis  was  NVUC  of  the  bladder.  The
patient  is  now  free  of  tumor  6  months  after
TUR-BT, but is strictly followed up. 
Case #2 
A 78-year-old man complained of hematuria,
and was admitted to our hospital. A blood lab-
oratory  test  showed  no  significant  changes.
Tumors markers were within normal ranges.
Bladder endoscopy revealed a nodular tumor
and  TUR-BT  was  performed.  Histo  logically,
carcinoma  cells  with  hyperchromatic  nuclei
were seen in the lamina propria (Figure 2A
and 2B). No tumor was seen in the surface
urothelium (Figure 2A). The carcinoma cells
formed small solid nests (Figure 1B). No tubu-
lar formations were seen. The histological fea-
tures  resembled  proliferated  von  Brunn’s
nests. The carcinoma cells had hyperchromat-
ic  and  enlarged  nuclei  (Figure  2B).  Mucin
stains were negative. Immuno  histochemically,
characteristic findings were positive cytoker-
atins, EMA, p63, p53 (Figure 2C), Ki-67 (label-
ing=30%) (Figure 2D), CD10, CEA, and MUC1
(Figure 2E) (Table 1). Since p53 was positive
and Ki-67 was relatively high, benign condi-
tions  such  as  proliferated  von  Brunn’s  nest
were denied. 
The final pathological diagnosis was NVUC
of the urinary bladder. The patient is now free
of tumor 15 months after TUR-BT, but is strict-
ly followed up.
Discussion
Usual urothelial carcinoma of the bladder
may show a nested pattern of invasion. Such a
tumor is not NVUC.1 NVUC of the bladder is
free from surface epithelial involvement.1-10 In
the  present  cases,  no  surface  involvements
were seen. Therefore, the present cases are
compatible with NVUC.
NVUC is characterized by the presence of
tumor cells in the lamina propria; the tumor
cells  are  bland  and  benign-looking.1-10 The
NVUC  shows  mild  atypia  in  the  superficial
part and relatively severe atypia in the deep
areas.  However,  anaplasia  is  seen  in  some
Case Report
Figure  2.  Case  #2.  A)  Low  power  view  of
nested variant of urothelial carcinoma of the
bladder. The atypical cells are present in the
lamina propria. The surface epithelial cells
are free of tumor. HE, x50. B) High power
view of A. The atypical cells show moderate
atypia, and take a form of nested pattern. The
features  resemble  hyperplastic  von  Brunn’s
nests. HE, x 200. C) The atypical cells are
positive for p53. Immunostaining , x200. D)
The atypical cells show Ki-67 antigen. The
Ki67-labeling  is  30%.  Immunostaining,
x200. E) The atypical cells show positive reac-
tion for MUC1. Immunostaining, x200.
A B
C D
E
Table 1. Immunohistochremical findings.
Case #1 Case #2
d-PAS --
AB --
CK AE1/3 +++ +++
CK CAM5.2 +++ ++
CK 34BE12 -+
CK5/6 -+
CK7 ++ ++
CK8 ++
CK14 --
CK18 ++ +
CK19 + ++
CK20 --
EMA ++
P63 - +++
P53 ++ ++
Ki67 15% 30%
PSA --
AMACR + ND
CD56 --
CD10 -+
Chromogranin --
Synaptophysin --
Vimentin --
S100 protein --
ASMA --
CA19-9 +-
CD34 --
NSE - ND
CEA -+
CA125 --
AFP - ND
MUC1 ++ ++
MUC2 --
MUC5AC --
MUC6 --
Foot note. CK, cytokeratin. EMA, epithelial membrane antigen. PSA,
prostate-specific antigen. AMACR, α-methylacyl CoA racemase
ASMA, α-smooth muscle antigen. NSE, neuron-specific enolase.
AFP, α-feto protein. ND, not done[page 134] [Rare Tumors 2011; 3:e42]
areas in the superficial parts. In the present
case #1, the atypia was mild, and resembled
nephrogenic metaplasia. In the present case
#2, the atypia was mild to moderate. In the
present two tumors, p53 was positive and Ki67
labeling was relatively high, suggesting that
the present cases are malignant. Therefore,
the  present  two  cases  are  compatible  with
NVUC of the bladder.
NVUC must be differentiated from promi-
nent von Brunn’s nest, cystitis glandularis and
cystica,  nephrogenic  metaplasia,  inverted
papilloma,  carcinoid,  prostatic  carcinoma,
paraganglion and paraganglioma.1 The pres-
ent tumors, particularly in case #2, are differ-
ent  from  von  proliferated  Brunn’s  nests,
because the present tumors showed mild atyp-
ia and immunohistochemical findings of posi-
tive p53 and relatively high Ki67 labeling. The
present  tumors  are  different  from  cystitis
glandularis  and  cystica  morphologically  and
immunohistochemically.  The  present  cases,
particularly  in  case  #1,  are  different  from
nephrogenic metaplasia, because the present
cases showed positive p53 and high Ki67 and
negative CD10 in case #1. The present cases
are different from inverted papilloma histolog-
ically and also because the present cases are
thought to be malignant. The present cases
are different from carcinoid tumor histologi-
cally and because the current cases were neg-
ative  for  neuroendocrine  markers  (chromo-
granin, synaptophysin, CD56 and NSE). The
present  cases  are  not  prostatic  carcinoma
because  of  negative  PSA.  The  current  two
cases  are  different  from  paraganglion  and
paraganglioma  because  of  positive  cytoker-
atins and negative neuroendocrine markers. 
Immunohistochemical study of NVUC has
been done in only one report.3 Wasco et al.,3
who demonstrated 30 cases of NVUC of the
bladder, demonstrated that NVUC was positive
for CK7 in 93%, CK20 in 68%, and p63 in 92%.
The present study is the first report of exten-
sive immunohistochemical features of NVUC.
In the present cases, CK7 was positive in 2/2,
CK20 was negative in 2/2, and p63 was posi-
tive in 1/2. The present study demonstrated
the CK immunoprofile; common findings were
positive  CDAE1/3,  CK  CAM5.2,  CK7,  CK8,
CK18, and CK19. CK14, and CK20 was nega-
tive in the two cases. EMA was positive in both
cases. p53 was positive in both cases and Ki67
labeling  was  relatively  high  in  both  cases.
CD10 was positive in 1/2 case. AMACR was
positive in 1/2 case. The positive reaction of
CEA and CA19-9 implies glandular differentia-
tion of NVUC. The positive MUC1 apomucin
also  implies  glandular  differentiation.  The
negative MUC2, MUC5AC and MUC6 suggest
that  these  apomucin  genes  were  not
expressed in NVUC. 
Clinically,  the  NVUC  affect  predominantly
male patients.1-10 Wasco3 showed that the male
to female ratio was 2.3:1. In the present cases,
one was male and another was female. The
NVUC  showed  aggressive  clinical  course  in
spite of the deceptively benign-appearing his-
tology.1-10 In the present two cases, the follow-
up periods are short; 6 and 15 months. The
present  cases  are  now  of  free  from  tumor.
Strict follow-up is needed in the present cases.
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